Epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase receptor that showed “gain of function” in many cancers through different mechanisms such as receptor overexpression, mutations, ligand-dependent receptor dimerization and ligand-independent activation [44]. This evidence concerns the gene EGFR and cancer.